Neuralink Receives FDA Approval for Human Brain Implant Trials

Elon Musk's brain-computer interface (BCI) startup, Neuralink, has received FDA approval for "in-human" trials of its surgically implanted brain device. The company was previously denied approval in 2022 over safety concerns, but it appears those have been resolved. The BCI is designed to help with medical and mobility issues and could eventually be marketed to the general public. Musk has proposed that BCIs would allow people to operate smartphones faster with their minds than they could with their thumbs. The potential use cases for the cryptocurrency and blockchain communities are also being explored.